US 12109239
Methods for production of human hemogenic endothelial cells from pluripotent stem cells and compositions thereof
granted A61KA61K35/19A61P
Quick answer
US patent 12109239 (Methods for production of human hemogenic endothelial cells from pluripotent stem cells and compositions thereof) held by Astellas Institute for Regenerative Medicine expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Astellas Institute for Regenerative Medicine
- Grant date
- Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K35/19, A61P, A61P17/02, A61P33/06